Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20215814 20155703 1.75 89 Palliative (P) 2020-01-20 2020-02-04 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101061546
20215821 20155704 1.82 49.9 Adjuvant (A) 2020-08-30 2020-09-05 Cetuximab + FOLFIRI cycle1 02 N OXALIPLATIN + RALTITREXED 101280153
20215826 20155705 1.62 70 Palliative (P) null 2019-08-11 Trial Unspecified 01 N TRIAL 101861939
20215829 20155706 1.79 96 Adjuvant (A) 2021-07-27 2021-08-08 Sorafenib 02 N SORAFENIB 101346484
20215839 20155707 1.71 73 null 2020-02-08 2020-02-22 EOX 2 Y CETUXIMAB + IRINOTECAN + MDG 101378891
20215842 20155708 1.57 61 Palliative (P) 2017-01-01 2017-01-08 Capecitabine 35days + RT 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101500517
20215848 20155709 1.79 40.6 Palliative (P) 2016-12-13 2016-12-13 Oxaliplatin + Raltitrexed 02 N OXALIPLATIN + RALTITREXED 101034392
20215850 20155710 1.64 94.6 null 2019-10-24 2019-10-24 EOX 02 null OXALIPLATIN + RALTITREXED 101503989
20215852 20155711 1.7 68.5 Palliative (P) 2016-10-10 2017-08-15 EOX 02 N EOX 101287213
20215863 20155712 1.57 93.9 Adjuvant (A) 2019-05-05 2019-05-19 Sorafenib 02 null SORAFENIB 101337589
20215865 20155713 1.87 77.6 Curative (C) 2019-06-18 2019-07-15 Trial Unspecified N Y TRIAL 100564415
20215869 20155714 1.6 100 Palliative (P) 2020-08-26 2020-09-10 EOX 99 N EOX 101706370
20215870 20155715 null 78.3 Palliative (P) 2019-03-19 2019-04-08 FLUOROURACIL + IRINOTECAN + Panitumumab 99 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101701784
20215871 20155716 1.79 47 Palliative (P) 2016-11-11 2017-02-24 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100947533
20215872 20155717 1.7 77.4 null 2020-01-20 2020-01-21 EOX 02 Y EOX 100252732
20215878 20155718 1.6 43 Neo-adjuvant (N) 2020-01-18 2020-01-31 CETUXIMAB + OXALIPLATIN + MDG 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100226979
20215881 20155719 1.63 72 Palliative (P) 2018-03-23 2018-04-21 Capecitabine 35days + RT N N CAPECITABINE + RT 101536499
20215882 20155720 1.63 75.9 Neo-adjuvant (N) 2019-10-09 2019-12-07 Sorafenib 02 Y SORAFENIB 100241007
20215883 20155721 null 120.4 Palliative (P) 2019-12-21 2020-01-11 EOX N N EOX 101605965
20215885 20155722 1.75 null Palliative (P) 2019-01-10 2019-02-07 EOX 02 N EOX 100759740
20215886 20155723 1.7 73 Palliative (P) 2018-09-27 2018-10-13 Trial Unspecified 02 N TRIAL 100401252
20215888 20155724 1.85 82 Adjuvant (A) 2019-03-24 2019-04-01 Capecitabine 5days + RT 02 N CAPECITABINE + RT 101653582
20215889 20155725 1.75 73.5 Curative (C) 2018-08-01 2019-10-23 Cetuximab + Oxaliplatin + MdG Maint 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100037911
20215890 20155726 1.54 73.4 Neo-adjuvant (N) 2017-09-03 2020-07-30 Sorafenib 02 N SORAFENIB 100065434
20215894 20155727 1.67 82.2 Palliative (P) 2018-04-13 2018-06-17 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101324131
20215900 20155728 1.59 73 Palliative (P) 2019-01-15 2019-03-30 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101000078
20215928 20155729 1.6 100 null 2020-06-08 2020-07-03 IRINOTECAN + MDG + PANITUMUMAB 02 Y FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100052320
20215934 20155730 null 76.4 null 2017-08-17 2017-08-25 Cetuximab + Oxaliplatin + MdG Maint 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101242766
20215936 20155731 1.79 null Palliative (P) 2020-10-20 2020-11-06 EOX 02 N OXALIPLATIN + RALTITREXED 101630201
20215940 20155732 1.78 66 null 2017-02-11 2017-02-11 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100027577
20215943 20155733 1.63 81.4 Palliative (P) 2018-11-13 2018-11-13 Sorafenib 02 null SORAFENIB 101049715
20215950 20155734 1.64 76 Disease modification (D) 2020-10-18 2020-11-20 EOX 02 Y EOX 101564066
20215961 20155735 1.83 118 03 2020-01-19 2020-02-10 Panitumumab + Irinotecan + MdG 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101620310
20215966 20155736 1.62 69.9 null 2019-11-16 2019-11-18 CAPECITABINE + RT N null CAPECITABINE + RT 100208596
20215973 20155737 1.79 81.6 Palliative (P) 2017-09-26 2017-10-05 Trial Unspecified 02 N TRIAL 101424322
20215974 20155738 1.75 125 null 2018-08-24 2018-08-26 EOX 02 null OXALIPLATIN + RALTITREXED 101771027
20215978 20155739 1.55 75.4 Adjuvant (A) 2021-03-06 2021-04-05 Oxaliplatin + Raltitrexed 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100567349
20215979 20155740 1.66 76.7 null 2020-05-16 2020-05-29 Oxaliplatin + Raltitrexed 02 N OXALIPLATIN + RALTITREXED 100155091
20215993 20155741 1.64 105 Palliative (P) 2019-04-24 2019-05-05 Cetuximab + FOLFIRI cycle 2 onwards 02 N OXALIPLATIN + RALTITREXED 101452238
20215996 20155742 1.67 90.7 Adjuvant (A) 2018-09-28 2018-09-28 GO2 TRIAL 99 N TRIAL 101737527
20215997 20155743 1.9 89.5 Palliative (P) 2019-08-04 2019-09-04 CETUXIMAB + IRINOTECAN + MDG 01 N CETUXIMAB + IRINOTECAN + MDG 101042616
20216001 20155744 1.78 66.4 Palliative (P) 2019-06-21 2019-06-22 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100690738
20216004 20155745 1.55 56.3 Not known (9) null 2022-02-09 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100298733
20216008 20155746 1.65 114.4 Curative (C) 2017-05-26 2017-08-03 Capecitabine 35days + RT 02 N EOX 100058043
20216009 20155747 1.7 91 Adjuvant (A) 2013-10-11 2016-08-11 EOX 2 N EOX 101693591
20216014 20155748 1.9 65.8 null 2019-06-29 2020-04-16 CAPECITABINE + RT 02 N CAPECITABINE + RT 101344523
20216015 20155749 1.54 75 null 2016-02-28 2016-04-09 Trial Unspecified Y null TRIAL 100791060
20216017 20155750 1.57 74 Disease modification (D) 2021-09-23 2021-09-24 IRINOTECAN + MDG + PANITUMUMAB 02 Y FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101490386
20216024 20155751 1.75 81 Palliative (P) 2017-07-29 2017-08-06 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101241366
20216028 20155752 1.82 51 Palliative (P) 2017-11-23 2018-01-04 EOX N Y TRIAL 101088180